Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

Michele De Palma, Craig Murdoch, Mary Anna Venneri, Luigi Naldini, Claire E. Lewis

Research output: Contribution to journalArticle

Abstract

Tumor-infiltrating myeloid cells are involved in crucial processes during tumor development. A subset of monocytes that express the angiopoietin receptor Tie2 play an important role in tumor angiogenesis. Selective depletion of these Tie2-expressing monocytes (TEMs) in tumor-bearing mice inhibits tumor angiogenesis and growth, suggesting that they might regulate angiogenic processes in tumors by providing paracrine support to nascent blood vessels. TEMs have also been identified in human blood and tumors. We discuss here the therapeutic opportunities emanating from the discovery of TEMs, which include the identification of new antitumor targets, monitoring TEMs as surrogate markers for clinical responses in cancer patients, and the possible use of TEMs as cellular vehicles for gene delivery to tumors.

Original languageEnglish
Pages (from-to)519-524
Number of pages6
JournalTrends in Immunology
Volume28
Issue number12
DOIs
Publication statusPublished - Dec 2007

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications'. Together they form a unique fingerprint.

  • Cite this